Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma

Among primary liver cancers, hepatocellular carcinoma is the most common pathological type. Its onset is insidious, and most patients have no obvious discomfort in the early stage, so it is found late, and the opportunity for surgical radical treatment is lost, resulting in a poor prognosis. With th...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tong Liu, Guorui Meng, Shihui Ma, Junqi You, Liang Yu, Risheng He, Xudong Zhao, Yunfu Cui
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-08-01
Edice:	Frontiers in Immunology
Témata:	hepatocellular carcinoma immune checkpoint inhibitors immunotherapy tumor immune microenvironment review
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1455716/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!